SANOFI PASTEUR, INC. (FORMERLY AVENTIS PASTEUR) for SANOFI PASTEUR INC (FORMERLY AVENTIS PASTEUR)
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Vaccine-related legislation, advance market commitments, and other issues Sean Callinicos-Staff Director and Chief Counsel, Senate Environment and Public Works Committee, Subcommittee on Clean Air and Nuclear Safety (1995-96) (John Chafee, R-RI, Chairman); General Counsel, Sen. Lauch Faircloth (R-NC) (97-98). Mary Anne Dunlap-Staff Member, Senate Environment and Public Works Committee.
Foreign entity interest: Sanofi-Aventis Group has an interest in this legislation due to the potential impact on their U.S. business.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | See Addendum |
| MARYANNE DOLBEARE DUNLAP | See Addendum |
| STUART FELDMAN | Legislative Assistant, Senator Orrin Hatch (R-UT) |
| AMY L REDL | — |
Taxation/Internal Revenue Code TAX
Legislation and other issues involving vaccine taxes and children's health, vaccine-related issues with respect to Medicaid and Medicare, and vaccine-related general tax issues. Sean Callinicos-Staff Director and Chief Counsel, Senate Environment and Public Works Committee, Subcommittee on Clean Air and Nuclear Safety (1995-96) (John Chafee, R-RI, Chairman); General Counsel, Sen. Lauch Faircloth (R-NC) (97-98). Mary Anne Dunlap-Staff Member, Senate Environment and Public Works Committee.
Foreign entity interest: Sanofi-Aventis Group has an interest in this legislation due to the potential impact on their U.S. business.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | See Addendum |
| MARYANNE DOLBEARE DUNLAP | See Addendum |
| STUART FELDMAN | Legislative Assistant, Senator Orrin Hatch (R-UT) |
| AMY L REDL | — |
Copyright/Patent/Trademark CPT
Patent Reform Issues. Sean Callinicos-Staff Director and Chief Counsel, Senate Environment and Public Works Committee, Subcommittee on Clean Air and Nuclear Safety (1995-96) (John Chafee, R-RI, Chairman); General Counsel, Sen. Lauch Faircloth (R-NC) (97-98). Mary Anne Dunlap-Staff Member, Senate Environment and Public Works Committee.
Foreign entity interest: Sanofi-Aventis Group has an interest in this legislation due to the potential impact on their U.S. business.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | See Addendum |
| MARYANNE DOLBEARE DUNLAP | See Addendum |
| STUART FELDMAN | Legislative Assistant, Senator Orrin Hatch (R-UT) |
| AMY L REDL | — |
Health Issues HCR
All vaccine and generic biological issues and related appropriation issues, including vaccines for children, pandemic concerns, influenza vaccine shortage issues, stockpile, bioterrorism, bioterrorism countermeasures, vaccine injury compensation programs, vaccine safety funding and financing, and FDA and cdc funding. Sean Callinicos-Staff Director and Chief Conusel, Senate Environment and Public Works Committee, Subcommittee on Clean Air and Nuclear Safety (1995-96) (John Chafee, R-RI, Chairman); General Counsel, Sen. Lauch Faircloth (R-NC) (97-98). Mary Anne Dunlap-Staff Member, Senate Environment and Public Work Committee.
Foreign entity interest: Sanofi-Aventis Group has an interest in this legislation due to the potential impact on their U.S. business.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | See Addendum |
| MARYANNE DOLBEARE DUNLAP | See Addendum |
| STUART FELDMAN | Legislative Assistant, Senator Orrin Hatch (R-UT) |
| AMY L REDL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.